Health Canada has released a statement acknowledging that the UK Medicines and Healthcare Products Regulatory Agency has issued a temporary authorisation for temporary limited supply of its first COVID-19 vaccine.
Health Canada has begun review of this vaccine on October 9, 2020 and is expected to come to a decision soon. The vaccine will only be authorised in Canada upon the successful completion of Health Canada’s independent review process to meet its stringent safety, efficacy and quality requirements.
MAP Online will continue to provide updates as the global rollout of the COVID-19 vaccine continues. Read the Health Canada statement for more information.